Vor Biopharma Inc
Vor Biopharma Inc. operates as a clinical-stage cell and genome engineering company. The company offers the Vor Bio platform, a technology platform for the treatment of acute myeloid leukemia (AML) and other blood cancers. It develops tremtelectogene empogeditemcel (trem-cel), a genome-edited hematopoietic stem and progenitor allogeneic donor product candidate to treat acute myeloid leukemia (AML… Read more
Market Cap & Net Worth: Vor Biopharma Inc (VOR)
Vor Biopharma Inc (NASDAQ:VOR) has a market capitalization of $539.76 Million ($539.76 Million) as of March 19, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #18509 globally and #6873 in its home market, demonstrating a -18.75% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Vor Biopharma Inc's stock price $13.00 by its total outstanding shares 41519840 (41.52 Million).
Vor Biopharma Inc Market Cap History: 2021 to 2026
Vor Biopharma Inc's market capitalization history from 2021 to 2026. Data shows change from $482.46 Million to $539.76 Million (-18.71% CAGR).
Index Memberships
Vor Biopharma Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.20 Trillion | 0.00% | #503 of 976 |
|
NASDAQ Composite
IXIC
|
$32.97 Trillion | 0.00% | #1697 of 3165 |
Weight: Vor Biopharma Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Vor Biopharma Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Vor Biopharma Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of VOR by Market Capitalization
Companies near Vor Biopharma Inc in the global market cap rankings as of March 19, 2026.
Key companies related to Vor Biopharma Inc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #165 globally with a market cap of $114.33 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #285 globally with a market cap of $73.32 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #340 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #497 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #165 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $114.33 Billion | $451.59 |
| #285 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $73.32 Billion | $744.12 |
| #340 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #497 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Vor Biopharma Inc Historical Marketcap From 2021 to 2026
Between 2021 and today, Vor Biopharma Inc's market cap moved from $482.46 Million to $ 539.76 Million, with a yearly change of -18.71%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $539.76 Million | -0.61% |
| 2025 | $543.08 Million | +1078.38% |
| 2024 | $46.09 Million | -50.67% |
| 2023 | $93.42 Million | -66.17% |
| 2022 | $276.11 Million | -42.77% |
| 2021 | $482.46 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of Vor Biopharma Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $539.76 Million USD |
| MoneyControl | $539.76 Million USD |
| MarketWatch | $539.76 Million USD |
| marketcap.company | $539.76 Million USD |
| Reuters | $539.76 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.